ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,377 | -15.3% | 16,619 | +19.1% | 0.00% | 0.0% |
| Q2 2023 | $393,501 | +43.7% | 13,949 | -12.4% | 0.00% | 0.0% |
| Q1 2023 | $273,807 | -14.6% | 15,919 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $320,609 | -12.9% | 15,919 | -6.4% | 0.00% | 0.0% |
| Q3 2022 | $368,000 | -23.0% | 17,009 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $478,000 | -5.3% | 17,009 | +55.3% | 0.00% | 0.0% |
| Q1 2022 | $505,000 | -45.1% | 10,949 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $920,000 | +32.9% | 10,949 | +5.5% | 0.00% | +100.0% |
| Q3 2021 | $692,000 | +27.2% | 10,378 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $544,000 | +40.6% | 10,218 | +14.4% | 0.00% | 0.0% |
| Q1 2021 | $387,000 | -15.5% | 8,930 | +1.2% | 0.00% | 0.0% |
| Q4 2020 | $458,000 | – | 8,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |